Background: Neuropsychological tests that can track changes in cognitive functions after diagnosis of Alzheimer disease (AD) and mild cognitive impairment (MCI), including episodic memory, should be further developed. Methods: The participants of our study consisted of 22 mild AD patients and 11 MCI patients. They were followed up for 2 years. Brief cognitive screening tests were administered to the participants. Longitudinal changes in test performance were evaluated and analyzed. Results: In this longitudinal study, the Scenery Picture Memory Test (SPMT) showed significant changes over 2 years in both MCI and AD participants. The Mini-Mental State Examination (MMSE) and Word Fluency Test-vegetable showed significant changes only in AD par...
OBJECTIVE: The aim of the present study was to evaluate the temporal change of the cognitive decline...
Mild Cognitive Impairment (MCI) was originally conceptualized as a condition that manifested prior ...
Objective: Alzheimer's disease (AD) studies are increasingly targeting earlier (pre)clinical populat...
International audienceOBJECTIVE: To investigate the sensitivity of a large set of neuropsychological...
In this study, we investigated the ability of commonly used neuropsychological tests to detect cogni...
The research of reliable procedures for predicting cognitive decline or stability in persons with am...
The aim of the current study was to test the accuracy of practice effects, that is, improvement in t...
Objective: Studies of Mild Cognitive Impairment (MCI) show elevated rates of conversion to dementia ...
Mild cognitive impairment (MCI) has emerged as a classification for a prodromal phase of cognitive d...
Abstract Cognitive changes in normal aging can be similar to the alterations that take place in the ...
Objectives Recent evidence suggests that a substantial minority of people clinically diagnosed with ...
Abstract Background Mild cognitive impairment (MCI) is a heterogeneous clinical entity that comprise...
Measures of cognitive change over time may help to better discriminate between mild cognitive impair...
Current management attempts for Alzheimer's disease (AD) focus on the identification of individuals ...
Abstract Mild Cognitive Impairment (MCI) can be an intermediate state between normality and dementia...
OBJECTIVE: The aim of the present study was to evaluate the temporal change of the cognitive decline...
Mild Cognitive Impairment (MCI) was originally conceptualized as a condition that manifested prior ...
Objective: Alzheimer's disease (AD) studies are increasingly targeting earlier (pre)clinical populat...
International audienceOBJECTIVE: To investigate the sensitivity of a large set of neuropsychological...
In this study, we investigated the ability of commonly used neuropsychological tests to detect cogni...
The research of reliable procedures for predicting cognitive decline or stability in persons with am...
The aim of the current study was to test the accuracy of practice effects, that is, improvement in t...
Objective: Studies of Mild Cognitive Impairment (MCI) show elevated rates of conversion to dementia ...
Mild cognitive impairment (MCI) has emerged as a classification for a prodromal phase of cognitive d...
Abstract Cognitive changes in normal aging can be similar to the alterations that take place in the ...
Objectives Recent evidence suggests that a substantial minority of people clinically diagnosed with ...
Abstract Background Mild cognitive impairment (MCI) is a heterogeneous clinical entity that comprise...
Measures of cognitive change over time may help to better discriminate between mild cognitive impair...
Current management attempts for Alzheimer's disease (AD) focus on the identification of individuals ...
Abstract Mild Cognitive Impairment (MCI) can be an intermediate state between normality and dementia...
OBJECTIVE: The aim of the present study was to evaluate the temporal change of the cognitive decline...
Mild Cognitive Impairment (MCI) was originally conceptualized as a condition that manifested prior ...
Objective: Alzheimer's disease (AD) studies are increasingly targeting earlier (pre)clinical populat...